Experimental Ebola Vaccine Administered To Some In D.C.

WASHINGTON -- Some people in the Washington, D.C. area may now be resistant to Ebola, if an experimental vaccine can live up to some very high expectations.

Since a clinical trial began Monday, seven people have been vaccinated, and the hope is to vaccinate six more on Thursday, according to Dr. Shon Remich, director of Translational Medicine at the Walter Reed Army Institute of Research in Silver Spring.

If no serious side effects are witnessed, others will be given stronger doses of the vaccine. The plan is for a total of 39 people to be vaccinated and studied over the coming seven to eight months.

More